Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > VM: Only 500 Shares Traded

<< Previous

Bullboard Posts

Next >>

Comment by ursusarctoson Feb 09, 2022 4:46pm

89 Views

Post# 34414285

RE:RE:RE:VM: Only 500 Shares Traded

Yes, agreed. Many stare at the share price now but fail to see the big picture. Excecution of the business plan, including FDA approval will move the valuation in it's time. No one who has made their DD are unaware of future financing needs, as it was a secret of some kind. Steady does it, 2022 will be a momentous year... Bashers are going to bash...

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario